M&A

Biosynex Entered into a Definitive Merger Agreement to Acquire Chembio Diagnostics for ~$17.2M

Biosynex Entered into a Definitive Merger Agreement to Acquire Chembio Diagnostics for ~$17.2M

Shots: Biosynex to acquire all outstanding shares of Chembio at $0.45/share repres...

Sun Pharma to Acquire Concert Pharmaceuticals for ~$576M

Sun Pharma to Acquire Concert Pharmaceuticals for ~$576M

Shots: Sun Pharma to acquire all outstanding shares of Concert. Concert stockholde...

APRINOIA Therapeutics to go Public via Ross Acquisition Corp II SPAC Merger for ~$319.6M

APRINOIA Therapeutics to go Public via Ross Acquisition Corp II SPAC Merger for ~$319.6M

Shots: The combined company will have a pro forma enterprise value of ~$319.6M. AP...

Elicio Therapeutics Entered into a Definitive Merger Agreement with Angion to Advance ELI-002 for Cancer

Elicio Therapeutics Entered into a Definitive Merger Agreement with Angion to Advance ELI-002 for Cancer

Shots: Elicio’s stockholders will receive newly issued shares of Angion comm...

BioNTech to Acquire InstaDeep for ~$683M

BioNTech to Acquire InstaDeep for ~$683M

Shots: InstaDeep to receive $440M up front & BioNTech shares, excl. the shares...

Ipsen to Acquire Albireo for ~$952M

Ipsen to Acquire Albireo for ~$952M

Shots: Ipsen to acquire all outstanding shares of Albireo at $42.00/share for an i...

Image